Skip to content

Interval-training and Appetite Regulation in Patients With Type 2 Diabetes

Interval-training and Appetite Regulation in Patients With Type 2 Diabetes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02592616
Enrollment
14
Registered
2015-10-30
Start date
2015-10-31
Completion date
2016-10-31
Last updated
2016-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

Exercise, Appetite, Energy intake

Brief summary

Four months of interval walking (IW) training results in substantial weight loss in opposition to energy-expenditure matched continuous walking (CW) training. The reason for this is unclear. This study will assess if IW leads to greater exercise-induced suppression of appetite and ad libitum food intake compared to CW and no exercise. Subjects with type 2 diabetes will be included in a crossover, counter-balanced, controlled study, where each subject will undergo three trials. Trials will be identical except the following interventions: 1. One hour of rest (CON) 2. One hour of interval walking (repeated cycles of 3 min of fast and 3 min of slow walking; IW) 3. One hour of continuous walking (CW) matched to IW with regards to energy-expenditure. After the interventions subjects will undergo a liquid mixed meal tolerance test (450 kCal), with regular measurements of appetite-related hormones (insulin, ghrelin, Leptin, Cholecystokinin, PYY). Three hours into the mixed meal tolerance test, a standardised ad-libitum meal test will be served and intake will recorded. Free-living energy intake via food records will be assessed during the following 32 hours.

Interventions

BEHAVIORALCON

No exercise intervention.

BEHAVIORALCW

One hour of continuous walking on a treadmill.

BEHAVIORALIW

One hour of interval (repeated cycles of 3 minutes of fast and 3 minutes of slow) walking on treadmill.

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Type 2 Diabetes Mellitus * BMI \> 25

Exclusion criteria

* Pregnancy * Smoking * Contraindication to increased levels of physical activity * Eating disorder * Insulin dependence

Design outcomes

Primary

MeasureTime frameDescription
Ad-libitum meal energy intakeInitiated 3 hours after the interventionSubjects will receive a standardized ad-libitum meal and energy intake will be assessed

Secondary

MeasureTime frameDescription
Free-living energy intakeFor 32 hours following the ad-libitum meal.Subjects will complete diet records for 32 hours following the ad-libitum meal and energy intake will be assessed.
Appetite-related hormonesRegularly during the 3 hours following the interventionAppetite-related hormones (insulin, ghrelin, leptin, cholecyctokinin, PYY) will be analysed in blood samples collected regularly during the liquid mixed-meal tolerance test following the intervention
SatietyRegular assessments for 36 hours following the interventionSatiety questionaires will be completed at regular intervals after the intervention

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026